Package 36000-364-01

{"route": ["INTRAVENOUS"], "spl_id": "9f2129bf-2527-42da-b07a-f20cac3246de", "openfda": {"nui": ["N0000178375", "N0000175788"], "upc": ["0336000364010"], "unii": ["2XLN4Y044H"], "spl_set_id": ["a81d66a7-b714-439e-ad7b-c7caf9d6f3b8"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (36000-364-01)  / 5 mL in 1 SYRINGE, PLASTIC", "package_ndc": "36000-364-01", "marketing_start_date": "20230523"}], "brand_name": "regadenoson", "product_id": "36000-364_9f2129bf-2527-42da-b07a-f20cac3246de", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adenosine Receptor Agonists [MoA]", "Pharmacologic Cardiac Stress Test Agent [EPC]"], "product_ndc": "36000-364", "generic_name": "regadenoson", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "regadenoson", "active_ingredients": [{"name": "REGADENOSON", "strength": ".08 mg/mL"}], "application_number": "ANDA217455", "marketing_category": "ANDA", "marketing_start_date": "20230523", "listing_expiration_date": "20261231"}